Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Simple methods using DHT levels effectively assess compliance.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Finasteride may help treat BPH by affecting certain biological markers.

The normal human prostate does not significantly affect blood DHT levels.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Herbal products for benign prostate hypertrophy need better quality checks to ensure safety and effectiveness.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

No link found between hair loss severity and PSA levels in men.

Finasteride reduces bleeding risk during prostate surgery.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

High serum DHT levels can help diagnose PCOS.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Finasteride treatment makes the prostate look more like a healthy one.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.